ABSTRACT
Strategies to reach CO₂ neutrality in pharma manufacturing through clean‑utility optimization, lifecycle CO₂ analysis, electrification, and process changes, highlighting challenges and benefits of shifting from fossil‑based to sustainable systems.
LED BY
Fritz Roeder, E&T Director, Merck Healthcare KGaA
Fritz Roeder is a pharmaceutical water and GMP utilities expert at Merck and chairs the ISPE Critical Utilities CoP. He also serves on the EDQM Water Working Group, contributing to European water monograph development.
Stefan Raabe, ISPE DACH CoP Critical Utilities Lead; Head of Strategic Account Management, Endress+Hauser Group
Stefan Raabe is Head of Strategic Account Management in Life Science Industry at Endress+Hauser, a biotechnology engineer with 31 years in the pharma manufacturing ecosystem and Chair of the ISPE DACH Critical Utilities Team.